eratoconus is a corneal ectatic disorder characterized by irregular astigmatism and mild to severe visual impairment. As the disease advances, approximately 20% of the patients require keratoplasty for visual rehabilitation.
T R A N S L A T I O N A L S C I E N C E
eratoconus is a corneal ectatic disorder characterized by irregular astigmatism and mild to severe visual impairment. As the disease advances, approximately 20% of the patients require keratoplasty for visual rehabilitation. 1, 2 The etiology of keratoconus is complex and multifactorial, involving both genetic and environmental factors. Our previous genome-wide association study identified 26 loci associated with central corneal thickness, among which FOXO1 and FNDC3B confer high risk for keratoconus. 2 Another exome sequencing analysis also reported the association of a WNT10A variant with corneal thickness and increased risk for keratoconus. 3 It is known that keratoconus pathology has a distinct anterior focus involving the epithelium and anterior corneal stroma with loss of cellular uniformity. 4 Transcriptome analysis of keratoconus corneal epithelium identified 56 differentially expressed genes in corneal epithelia, which participate in extracellular matrix remodeling, cell-cell/cell-matrix interactions, and transmembrane signaling. 5 Proteomic analysis showed that cytokeratin-3, cytokeratin-12, gelsolin, S100A4, and enolase-1 are differentially expressed in keratoconic corneal epithelia. 6 These studies indicate the possible pathological changes in keratoconic corneal epithelia. Normal corneal epithelium accounts for approximately 10% of the corneal thickness. The keratoconus K ABSTRACT PURPOSE: To illustrate the histopathology of keratoconic corneal epithelia and its micro-ribonucleic acid (miRNA) regulation.
METHODS:
Corneal epithelia were collected from 27 patients with keratoconus and 26 normal patients after surgery or by impression cytology. The miRNA profile was determined using miRNA microarray. The biological roles of miRNA target genes were delineated by gene ontology and pathway analyses. The expressions of significant miRNAs were validated using TaqMan polymerase chain reaction (PCR), whereas protein localization and expression of the miRNA target genes were examined by immunofluorescence and immunoblotting analyses.
RESULTS:
Histological assessment showed that corneal epithelia in patients with keratoconus were thinner with loosely packed cells compared to normal patients. Microarray analysis revealed that 12 miRNAs were significantly downregulated in keratoconic corneal epithelia. Gene ontology analysis demonstrated that the predicted miRNA target genes participated in cell junction, cell division, and motor activity, whereas pathway analysis highlighted the involvement of syndecan-mediated signaling pathway. TaqMan PCR validated the altered expression of six miRNAs in corneal epithelia from surgery (hsa-miR-151a-3p, hsa-miR-138-5p, hsa-miR-146b-5p, hsa-miR-194-5p, hsa-miR-28-5p, and hsa-miR181a-2-3p) and four miRNAs in squamous corneal epithelial samples collected from impression cytology (hsa-miR-151a-3p, hsa-miR-195-5p, hsa-miR-185-5p, and hsa-miR-194-5p). In addition, higher S100A2 expression was found in the epithelial basal cell layer of keratoconic corneal epithelia.
CONCLUSIONS:
The miRNA and histological analyses in this study demonstrated structural and biological changes in keratoconic corneal epithelia, broadening the understanding of keratoconus pathology. In addition, impression cytology is useful to collect corneal epithelial tissues for gene expression analysis.
[J Refract Surg. 2018;34(3): 201-211.] epithelial corneal thickness profile using Artemis very high-frequency digital ultrasound scanning (ArcScan, Inc., Golden, CO) demonstrated localized central thinning surrounded by an annulus of thickened epithelium. 7 Fourier-domain optical coherence tomography demonstrated parameters based on corneal epithelial thickness that could differentiate keratoconic from normal eyes with high accuracy. 8 In vivo confocal microscopy and histological analyses have confirmed that basal epithelial cells in keratoconic corneas exhibited irregular arrangement and a significant reduction in cell density when compared to normal corneas. 4 The epithelial apoptosis could be a possible reason for the corneal epithelium thinning. 9 Micro-ribonucleic acids (miRNAs) belong to a family of 18 to 24 nucleotide non-coding RNAs that negatively regulate the translation of messenger RNA. The miR-184 mutations and miR-568 polymorphism have been found to be associated with keratoconus. 10 A recent deep sequencing analysis on different normal human ocular tissues identified 297 miRNAs expressed in the cornea, and 9 of them could target the genes associated with keratoconus (DOCK9, FNDC3B, FOXO1, and RAB3GAP1). 11 Yet, miRNA regulation in keratoconic corneal epithelium has not been studied. In this study, we aimed to illustrate the histophathology and miRNA regulation of corneal epithelial changes in keratoconic patients. Corneal epithelia were collected from patients with keratoconus and normal patients during surgery and their histological structures were resolved. The miRNA profiles were delineated by microarray and miRNA target genes were analyzed. In addition, the translational potential of the miRNA expression was confirmed in the corneal epithelial samples obtained by impression cytology.
PATIENTS AND METHODS

Study PatientS
This prospective study involved a total of 53 consecutive participants (27 keratoconic and 26 normal) recruited from The Chinese University of Hong Kong Eye Centre. The diagnosis of keratoconus was made based on retinoscopic signs ("red" reflex on direct ophthalmoscopy), biomicroscopic signs (Vogt's striae, Fleischer's ring, and corneal scarring) and corneal tomography using swept-source optical coherence tomography (Casia; Tomey Corporation, Nagoya, Japan). For the normal cohort, the study patients with no ocular abnormality except myopia and myopic astigmatism, a corrected distance visual acuity of 20/20 or better, and stable refraction for more than 1 year were included. All of them had photorefractive keratectomy. Patients with a corneal thickness of less than 500 µm, suspicion of keratoconus on corneal topography (displacement of the corneal apex, decrease in thinnest-point pachymetry, and asymmetric topographic pattern), ocular inflammation, and infection were excluded. The Ethics Committee for Human Research of The Chinese University of Hong Kong approved the study protocol. The protocol followed the tenets of the Declaration of Helsinki. An informed consent was obtained from each study patient after explanation of the nature and possible consequences of the study.
ColleCtion of Corneal ePithelia
Central corneal epithelia (8 to 9 mm) of the study patients were collected during photorefractive keratectomy (normal patients) or corneal cross-linking (patients with keratoconus). The corneal epithelium samples were immediately washed with phosphate buffered saline (PBS) (0.01 M, pH 7.5; Amresco, Solon, OH) and stored in TRIzol (for RNA extraction; Invitrogen, Carlsbad, CA) or radioimmunoprecipitation assay (RIPA) buffer (for protein extraction; Sigma-Aldrich, St. Louis, MO) at -80°C or fixed with 10% formalin (for histological analysis; Sigma-Aldrich) at 4°C before further experiments. In addition to the surgical specimens, the squamous layer of the corneal epithelia was also collected using an impression cytology device (EYEPRIM; OPIA Technologies SAS, Paris, France). The EYEPRIM device comes with a 69-mm 2 , 0.2 µm-thick polysulfone membrane on one end and a plunger on the other end. Briefly, the patient was asked to look straight ahead with chin lifted slightly. A drop of preservative-free local anesthetic eye drops was instilled in the lower fornix of the eye. The plunger was pushed to touch the cornea with the membrane gently for 5 seconds. The pressure was released before removing the device. The membrane was carefully transferred from the device into a 1.5-mL tube using a pair of sterile forceps. Two EYEPRIM membranes were collected for each eye. The membranes were immediately stored in TRIzol reagent at -80°C for further miRNA analysis.
hiStologiCal analySiS
The corneal epithelia were fixed in 10% formalin, processed, and embedded in paraffin. The histological structure of the corneal epithelia in the paraffin section (5 µm) was visualized after hematoxylin-eosin staining. Briefly, the paraffin sections were dewaxed in xylene and rehydrated in 100% to 70% ethanol gradients. The sections were then stained with hematoxylin-eosin solution (Sigma-Aldrich) according to the recommended protocol. The stained sections were dehydrated and mounted. The morphological structure of corneal epithelia was visualized and im-aged under a light microscope (Eclipse Ti-E; Nikon, Tokyo, Japan). The number of squamous, wing, and basal cells in normal and keratoconic corneal epithelium sections (10 sections per sample; 3 samples in each group) were counted and compared.
The total RNA, including the miRNA fraction, in TRIzol reagent was extracted according to the manufacturer's protocol (Invitrogen). The RNA concentration and quality were measured with Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA), whereas the RNA integrity was determined using the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). Human miRNA microarray slide (8 × 60K, release 19.0, G4872A; Agilent Technologies, Inc.) containing 2,006 human miRNAs from the Sanger miRBase (release 19.0) was used. GeneSpring GX 13.0 software (Agilent Technologies, Inc.) was used for value extraction and data analysis. A moderated t test was used for calculation of the P value for each miRNA probe. Significance was defined by a change greater than 1.5 fold and corrected P value less than .05. The Benjamin-Hochberg false discovery rate was used for adjustment of multiple tests. Principal component analysis (PCA) and hierarchical clustering were performed to provide a visual impression of how various sample groups were related. Two samples of normal corneal epithelium and two samples of keratoconic corneal epithelium were used for miRNA microarray experiment.
Downstream target genes of differentially expressed miRNAs were predicted by five databases (TargetScan, microRNA.org, TarBase, PicTar, and PITA) in the GeneSpring GX 13.0 software. Gene enrichment and gene ontology analysis were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 6.8 (http:// david.abcc.ncifcrf.gov/). An enrichment score greater than 1.3 was considered significant. Pathway analysis and gene interaction were performed using FunRich software (version 2.1.2; http://funrich.org).
Eleven differentially expressed miRNAs from microarray with greater than 10 fold change were subjected to further TaqMan validation. Six independent surgical corneal epithelial samples and eight independent impression cytology samples from each group were used in the validation experiments. Total RNA (20 ng) was reverse transcribed using the TaqMan MicroRNA Reverse Transcriptase kit (Applied Biosystems, Foster City, CA). The resultant products were quantified using the corresponding TaqMan MicroRNA Assays (Applied Biosystems) on LightCycler 480 Instrument II (Roche Diagnostics Corporation, Indianapolis, IN). Their expressions were normalized to that of U6.
immunofluoreSCenCe analySiS
Immunofluorescence analysis was used to determine the protein location and expression of the miRNA target genes in the corneal epithelia. Briefly, the paraffin sections of corneal epithelium, after they were dewaxed and rehydrated, were incubated in freshly prepared ice-cold 50 mM ammonium chloride (Sigma-Aldrich) in PBS for 2 minutes to quench the free aldehyde and retrieve the antigen. The sections were then blocked in PBS supplemented with 1% bovine serum albumin (BSA), 0.15% saponin, and 0.01% Triton X-100 (all Sigma-Aldrich) for 2 hours, and incubated with the primary antibodies (Table A, available in the online version of this article) in PBS supplemented with 1% BSA, 0.425% saponin, 0.0015% Triton X-100, and Tween-20 (Sigma-Aldrich) at 4°C for 18 hours. After PBS washes, the sections were incubated with corresponding secondary antibodies conjugated with Alexa-488 and 4',6'-diamidino-2-phenyindole (DAPI; for nuclear counter-stain) in PBS supplemented with 1% BSA for 1 hour at room temperature. The fluorescence signals were visualized and imaged under a fluorescence microscope (Eclipse Ti-E).
immunoblotting analySiS
The protein expression of miRNA-predicted target genes was semi-quantified by immunoblotting analysis. Briefly, the corneal epithelia were lysed in RIPA buffer supplemented with protease and phosphatase inhibitors (Roche). Total protein concentration of cell lysates was quantified using the Protein assay (BioRad Laboratories, Hercules, CA). An equal amount of denatured protein samples (20 µg) was resolved with 10% or 15% SDS-PAGE gels, electro-transferred onto a nitrocellulose membrane and incubated with the primary antibodies (Table A) at 4°C for 18 hours, followed by incubation of the corresponding horseradish peroxidase (HRP)-conjugated secondary antibodies at room temperature for 1 hour. The signals were then detected using enhanced chemiluminescence (ECL) substrate (Amersham Pharmacia, Cleveland, OH) and captured by the ChemiDocTM XRS+ system (BioRad). Beta-actin was used for normalization. Relative expressions of target proteins were measured and calculated by Quantity One software (BioRad).
StatiStiCal analySiS
Means of the keratoconic and normal groups were compared using the independent t test. All of the statistical analyses, except the microarray analysis, were performed using the commercially available software (SPSS version 22.0; SPSS, Inc., Chicago, IL). A P value of less than .05 was considered statistically significant.
RESULTS
CliniCal aSSeSSmentS of Study PatientS
The mean age of patients with keratoconus (n = 27; 29.75 ± 8.02 years) was comparable to that of the normal patients (n = 26; 33.39 ± 8.22 years; P = .070). Significant differences in corneal topographic parameters between the two studied groups were observed in anterior and posterior keratometry at steep axis (K s ), keratometry at flat axis (K f ), and average keratometry (K avg ) (P < .001) ( Table 1 ). The swept-source optical coherence tomography images showed thin and conical cornea in patients with keratoconus compared to the normal patients (Figure A , available in the online version of this article).
hiStologiCal analySiS of KeratoConuS Corneal ePithelium
The histological structure of surgical corneal epithelial specimens was assessed by hematoxylin-eosin staining. The corneal epithelia from normal patients were compact and tightly packed, whereas those from patients with keratoconus were thinner and loosely arranged ( Figure 1A) . The number of squamous cells, wing cells, and basal cells in the keratoconic corneal epithelia were 3.01 ± 0.53, 9.08 ± 1.41, and 7.42 ± 0.94 cells/100 µm, respectively, which were all significantly fewer than those in normal patients (6.42 ± 1.04, 20.48 ± 3.35, and 11.06 ± 1.00 cells/100 µm, respectively, P < .001; Table 2, Figure 1B) . Immunofluorescence analysis of p53 protein on corneal epithelial sections showed an increased p53 protein expression in squamous and wing cell layers of keratoconic corneal epithelia ( Figure 1C) . mirna 
Profiling and Validation
The global miRNA profile (miRNome) of normal and keratoconic corneal epithelia collected from surgery was determined by microarray. PCA (Figure 2A ) and hierarchical clustering analysis ( Figure 2B ) demonstrated that the miRNA expression profiles of normal and keratoconic corneal epithelia were clustered separately. Of the 2,006 human miRNAs, 137 miRNAs showed more than 1.5-fold expression changes in the keratoconic corneal epithelia. The volcano plot identified 12 significant (P corr < .05 and > 1.5 fold change) differentially expressed miRNAs (hsa-miR-4713-3p, Figure 2C ), all of which were downregulated in the keratoconic corneal epithelia ( Table B , available in the online version of this article). In addition, we also confirmed that human corneal miRNAs were abundantly expressed in our samples (Table C, available in the online version of this article).
hsa-miR-151a-3p, hsa-miR-193b-5p, hsa-miR-138-5p, hsa-miR-195-5p, hsa-miR-185-5p, hsa-miR-146b-5p, hsa-miR-194-5p, hsa-miR-28-5p, hsa-miR-6126, hsamiR-181a-2-3p, and hsa-miR-30e-3p;
Eleven miRNAs with greater than 10-fold differential expression were selected for TaqMan PCR validation using 12 additional independent surgical corneal epithelial samples. Of the 11 tested miRNAs, six miRNAs Table  B ). This validated the differential miRNA expressions between normal and keratoconic corneal epithelia.
gene ontology and Pathway analySeS of mirna target geneS The 12 differentially expressed miRNAs in the microarray experiment were further applied for prediction of their target genes based on the Human hg19 (UCSC) database in the GeneSpring software. A total of 1,150 significant target genes were predicted from the five databases in the GeneSpring software (P < .05). Gene ontology analysis by DAVID (1,145 DAVID identities) demonstrated that the predicted miRNA target genes are involved in cell junction (5.68%, P = 5.79 × 10
), cell division (3.06%, P = 3.31 × 10 -3 ), microtubule (2.53%, P = 1.22 × 10 -2 ), and motor activity (1.05%, P = 1.32 × 10 -3 ; Table 3 ). Pathway analysis by FunRich (1,071 FunRich identities) suggested that the predicted miRNA target genes could possibly be involved in the syndecan-mediated signaling pathway (30.4%, P < .001), vascular endothelial growth factor (VEGF), and VEGF receptor (VEGFR) signaling pathway (29.3%, P < .001), endothelins (29.3%, P < .001), PDGF receptor signaling network (29.1%, P < .001), integrin family cell surface interactions (30.6%, P < .001), IFN-gamma pathway (29.1%, P < .001), and ErbB receptor signaling network (29.3%, P < .001; Figure 3) . The predicted target genes are interactively connected in a vast network (Figure B , available in the online version of this article). Moreover, the FunRich analysis also identified that SLC2A10, ANTXR1, and ZNF469 from our predicted gene list were associated with keratoconus (Table D, available in the online version of this article).
In comparison with previous transcriptomic, genetic, and proteomic studies (Table D) , 3, 5, 12 four genes (CEACAM6, FHL2, S100A2, ARF3) from our predicted miRNA target gene list were in common with the tran- 5 four genes (LRRK1, FNDC3B, RXRA, ZNF469) with our previous GWAS analysis, 3 and three genes (INSR, VEGFA, PPARGC1A) with the proteomic study, 12 indicating that our miRNA profile could be coherent to the mechanisms of keratoconic corneal epithelial changes from different investigations. 
Histological and microRNA Signatures in Keratoconus/Wang et al
Protein exPreSSion of mirna target geneS
To characterize the role of miRNAs in keratoconic corneal epithelia, two miRNA target genes (S100A2 and PTK2; Table E, available in the online version of this article) were selected and further evaluated by immunofluorescence analysis. We observed a higher expression of S100A2 protein, which was predicted to be regulated by hsa-miR-138-5p and hsa-miR-185-5p (Table D) , in the basal cell layer of keratoconic corneal epithelia compared to that of normal corneal epithelia (Figure 4 and Figure B) . In contrast, focal adhesion kinase (FAK; PTK2) only showed slightly increased expression in the wing cell layer as compared to the normal corneal epithelia. The immunofluorescence results were further confirmed by immunoblotting analysis. S100A2 protein expression in keratoconic corneal epithelia was 2.49-fold higher than in normal corneal epithelia (P < .05; Figure 5 ), whereas FAK protein expression did not show a significant difference between keratoconic and normal corneal epithelia (1.12-fold, P = .591). These findings suggested that the downregulation of hsa-miR-138-5p and hsa-miR-185-5p could be correlated with the upregulation of S100A2 protein in keratoconic corneal epithelia.
mirna exPreSSion in Corneal SquamouS ePithelia ColleCted from imPreSSion Cytology
The impression cytology can obtain squamous cells of the corneal epithelia without the necessity of surgery, and the samples showed corneal epithelial marker (KRT3) expression (Figure 6A) . We evaluated the expression of microarray-identified miRNAs by TaqMan PCR on 16 corneal samples collected using impression cytology. Of the 11 tested miRNAs, 4 were significantly downregulated in keratoconic corneal epithelia compared to the normal samples (hsa-miR-151a-3p, 5.01 fold, P = .036; hsa-miR-195-5p, 38.78 fold, P < .001; hsa-miR-185-5p, > 100 fold, P = .013; and hsamiR-194-5p, 46.49 fold, P = .011; Figure 6B ). DISCUSSION Keratoconus has long been described as a corneal stromal disease. However, in vivo confocal images showed abnormal features in every layer of the cornea, including abnormal epithelial and stromal keratocytes. 8 Microscopic features of keratoconic corneas indicated irregular arrangement in basal epithelial cells, 4, 8 reduction in basal epithelial cell and keratocyte densities, 4, 13 and epithelial apoptosis along with Histological and microRNA Signatures in Keratoconus/Wang et al corneal epithelium thinning. 9 Likewise in our study, the keratoconic corneal epithelial cells were loosely arranged ( Figure 1A ) and significantly fewer in number compared to normal corneal epithelia ( Figure  1B) . The apoptosis-related marker, p53 protein, was upregulated in keratoconic corneal epithelia ( Figure  1C) , suggesting degeneration of this layer. Previous proteomic studies also identified a marked increase in apoptosis-related proteins, including p53 protein, in corneal epithelia. 6, 12 In addition, because the cathepsins are involved in the apoptotic pathway, 14 the elevated corneal expression of cathepsin B and G in keratoconus indicates that cell apoptosis occurs in keratoconic corneal epithelia. 15 The upregulation of interleukin-6, tumor necrosis factor-α, and matrix metalloproteinase-9 in tears and corneal epithelia of patients with keratoconus further suggests the presence of chronic inflammation, cell apoptosis, and destruction of cell integrity in keratoconic corneal epithelia. 16 Lysyl oxidase, which is essential for stabilization, integrity, and elasticity of collagen fibrils, is decreased in keratoconic corneal epithelia. 17 A previous transcriptome study on keratoconic corneal epithelia also suggested changes in cytoskeleton, reduced extracellular matrix remodeling, and modified cell-to-cell and cellto-matrix interactions. 5 Together with the gene ontology analysis on cell adhesion and cell division predicted from the miRNA target genes in our study (Table 3) , these findings imply that cell integrity alteration and cell apoptosis are the possible pathological changes in the degeneration of corneal epithelium in keratoconus.
The miRNA regulation is one of the possible pathological mechanisms in various corneal diseases, including diabetic corneal nerve regeneration, 18 Pseudomo- Figure 4 . Immunofluorescence analysis of S100A2 and focal adhesion kinase (FAK) proteins in normal and keratoconic corneal epithelia. Higher expression of S100A2 protein was observed in the basal cell layer of keratoconic corneal epithelium compared to that of normal corneal epithelium, whereas FAK only showed slightly increased expression in the wing cell layer. Figure 5 . Immunoblotting analysis of S100A2 and focal adhesion kinase (FAK) proteins in normal and keratoconic corneal epithelia. S100A2 protein expression in keratoconic corneal epithelium was 2.49 fold higher than that in normal corneal epithelium (P < .05), whereas FAK protein expression did not show a significant difference between keratoconic and normal corneal epithelia (1.12 fold, P = .591). Beta-actin was used as a housekeeping protein.
Histological and microRNA Signatures in Keratoconus/Wang et al nas aeruginosa-induced keratitis, 19 and keratoconus. 10 With reference to the recent deep sequencing analysis on normal human cornea, 20,21 297 miRNAs were identified and expressed in human cornea, with which 172 miRNAs have an average expression signal greater than 5 ( Table C) . Our microarray analysis identified 211 miRNAs in our corneal epithelial samples and 94 miRNAs (55%) were commonly expressed when compared to the deep sequencing study, suggesting the corneal specificity of our samples as indicated by our miRNA profile. Moreover, the deep sequencing analysis on normal human cornea also suggested that miR-143-3p, miR-153-3p, miR-182-5p, miR-183-5p, miR-186-5p, miR-223-3p, miR-27a-3p, miR-9-5p, and miR-96-5p could target the genes associated with keratoconus (DOCK9, FNDC3B, FOXO1, and RAB3GAP1).
11
In our study, 12 human miRNAs were downregulated in keratoconic corneal epithelia by microarray analysis (Table B) . Using TaqMan PCR, we confirmed the downregulation of six miRNAs in corneal epithelia from surgery and four miRNAs in squamous corneal epithelial samples collected from impression cytology, suggesting that they could potentially be applied for keratoconus prediction.
The miR-151a has been found to be expressed differentially in atopic dermatitis (an inflammatory disease) 21 and Alzheimer's disease (a neuronal degenerative disease), 22 and inhibition of miR-151a is related to suppression of tumor growth. 23 The miR-194 plays a crucial role in tumor progression and inhibits proliferation and metastasis in cancer cells.
24 These findings suggest that downregulation of these miRNAs in keratoconic corneal epithelium could contribute to its degenerative processes, including promotion of cell apoptosis and inhibition of cell migration, as indicated by our gene ontology analysis of miRNA target genes ( Table 3) .
Previous transcriptome analysis identified 56 candidate genes differentially expressed in keratoconus samples, 5 and four of them (CEACAM6, FHL2, S100A2, and ARF3) are in common with our predicted miRNA target genes ( Table D) . We selected S1002A (predicted to be regulated by hsa-miR-138-5p and hsa-miR-185-5p) and PTK2 (predicted to be regulated by hsa-miR-138-5p) for further analysis, especially the former being reported in the transcriptome study (Table D) and involved in the proteoglycan syndecan-mediated signaling pathway (Figure 3, Figure C , available in the , and hsa-195-5p were significantly downregulated in keratoconic corneal epithelium, whereas hsa-193b-5p was significantly upregulated. *P < .05; **P < .01; ***P < .001.
online version of this article, and Table E), whereas PTK2 is involved in cell adhesion and motor activity. 25 We confirmed that S1002A protein expression is upregulated in keratoconic corneal epithelia (Figure 5) , with a specific location in the epithelial basal cell layer (Figure 4) . Our findings are concordant with a previous immunohistochemistry study. 26 The pathway analysis of our miRNA target genes identified the proteoglycan syndecan-mediated signaling pathway, integrin family cell surface interactions, and VEGF and VEGFR signaling pathway (Figure 3) . A study on syndecan-1 knockout mice identified the role of syndecan-1 in mediating cell proliferation and regulation of integrin expression in normal and wounded corneal epithelial tissues.
27
Loss of syndecan-1 in corneal stromal cells could influence cell migration rates, fibrillar adhesions, and integrin activation. 28 Therefore, syndecan-mediated signaling pathway-related cell migration and cell adhesion closely match our gene ontology analysis of miRNA target genes ( Table 3 ). The S100A2 involved in the proteoglycan syndecan-mediated signaling pathway (Table E) has been shown to be upregulated in keratoconic corneal epithelia in previous immunohistochemistry study 26 and in our protein expression analyses (Figures 4-5) , suggesting that the proteoglycan syndecan-mediated signaling pathway dysregulation could be a potential mechanism for keratoconic corneal epithelia degeneration. How the proteoglycan syndecan-mediated signaling pathway is involved in keratoconus and whether other mechanisms, such as VEGF pathway and integrin family cell surface interactions, could be involved warrants further investigation. Nevertheless, a previous proteomic study identified VEGFA as a predicted upstream regulator in keratoconic corneal epithelia, 12 and this also matches with miRNA target genes in our study ( Table D) .
To translate our findings of miRNA expression into clinical application, we evaluated the EYEPRIM conjunctival impression cytology device, which can procure cells from squamous corneal epithelia for biological testing without the necessity of surgery. The device allows quick sampling of conjunctival cells, which can then be analyzed for dry eye biomarkers. 29 We used it for collection of corneal epithelia for the first time. In our study, we confirmed that the samples collected by impression cytology are cornea-specific because they expressed the corneal epithelial marker (Figure 6A) . We propose that the EYEPRIM or an equivalent device can be used as a molecular diagnostic tool for corneal diseases. The miRNA expression of the EYEPRIM-collected squamous corneal epithelial cells could be a convenient and feasible method for keratoconus prediction (Figure 6B) .
This study resolved the histological structure of keratoconic corneal epithelia and identified cell apoptosis, cell integrity alteration, and the downregulation of miRNAs as the potential mechanisms for keratoconic corneal epithelial degeneration. In addition, impression cytology is a useful modality to collect and analyze the miRNA expression of corneal epithelia. 
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